Newstral
Article
bizjournals.com on 2019-10-23 13:22
In reversal, Biogen to file for approval of Alzheimer's drug
Related news
- In reversal, Biogen to file for approval of Alzheimer's drugbizjournals.com
- WAlzheimer's drug from Biogen, partner receives FDA approvalwraltechwire.com
- BA Third Expert Quits FDA Panel Over Approval of Biogen Alzheimer's Drug 2 minbarrons.com
- Biogen, Eisai to push for fast FDA approval for second Alzheimer's drugbizjournals.com
- The Petri Dish: Biogen seeks accelerated approval for second Alzheimer's drugbizjournals.com
- MRegulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer's drug success as shares soar2 min readmarketwatch.com
- FBiogen to seek Alzheimer’s drug approvalft.com
- Biogen trial drug shows promise in fight against Alzheimer'sThe Japan Times
- Biogen says new drug shows promise in combating Alzheimer'smetro.us
- Biogen defends Alzheimer's drug, highlights pipeline at J.P. Morgan conferencebizjournals.com
- Biogen shares soar as FDA reviewers support Alzheimer's drugSydney Morning Herald
- Biogen to cease production of controversial Alzheimer's drugPOLITICO
- Biogen reworks Alzheimer's drug pacts in bullish movebizjournals.com
- Biogen stock gains on leaked Alzheimer's drug databizjournals.com
- Biogen touts ‘resilience’ but gives little guidance on Alzheimer's drugbizjournals.com
- Biogen lays out plans for confirmatory study of Alzheimer's drugbizjournals.com
- Biogen And Eisai Present Positive Results For Experimental Alzheimer's DrugForbes
- FDA seeks inquiry on Alzheimer's drug approvalArkansas Online
- Biogen's Alzheimer's drug wins FDA approvalbizjournals.com